Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy

Clinical trial NCT05394740 · COMPLETED

Trial details

NCT number: NCT05394740
Sponsor: National Cancer Center Hospital East
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2022-06-06
Primary completion: 2024-04-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.